BNET Industries

Stereotaxis Inc.

(STXS) is in the Health Care Industry

Market Cap:$198.5M
Last Fiscal Year Sales:$40.3M
  • Public
  • US
Dow Jones Description

We design, manufacture and market an advanced cardiology instrument control system for use in a hospitals interventional medical suite, or interventional lab, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling important new therapeutic solutions and enhancing the efficiency and efficacy of existing catheter-based, or interventional, procedures. Our Niobe ® system allows physicians to more effectively navigate proprietary catheters, guidewires and other delivery devices, both our own and those we are co-developing with strategic partners, through the blood vessels and chambers of the heart to treatment sites in order to effect treatment. This is achieved using computer-controlled, externally applied magnetic fields that precisely and directly govern the motion of the internal, or working, tip of the catheter, guidewire or other interventional device. We believe that our Niobe system represents a revolutionary technology in the interventional lab, bringing precise remote digital instrument control and programmability to the interventional lab, and has the potential to become the standard of care for a broad range of complex cardiology procedures. Our Odyssey Total Information Solution allows physicians to utilize a consolidated user interface and single mouse and keyboard control for multiple systems within the interventional lab. ...

Number of Employees 183
Contact Information

4320 Forest Park Ave Ste 100

Saint Louis, Missouri 63108

stereotaxis.com

(314) 678-6172

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • Stereotaxis cuts loss

    11/05/09 - Financial Announcement - View Story

  • Stereotaxis raises more than $29M in public offering

    10/19/09 - New Investment - View Story

  • Soleil Securities Initiates Coverage on Stereotaxis STXS with a Buy

    10/06/09 - Bond / Stock Rating - View Story

  • Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009

    9/24/09 - Product Announcement - View Story

  • CFOs on the Move: Week Ending August 7

    8/06/09 - Mgmt. Change Entering - Other - View Story

  • Stereotaxis names CFO

    8/06/09 - Mgmt. Change Leaving - CFO - View Story

  • Stereotaxis names Daniel Johnston as CFO

    8/06/09 - Mgmt. Change Entering - CFO - View Story

  • Stereotaxis Q2 Loss Narrows; Names New CFO - Update

    8/06/09 - Financial Announcement - View Story

News & Analysis

stereotaxis inc. - All News and Analysis

advertisement
     STXS $3.95 +0.12 (3.13% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 327,146
Shares Outstanding 42.75M
Market Cap 168.9M
Year High 5.19
Year Low 2.3
Earnings Per Share -0.70
P/E Ratio -5.64
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here